MHCII/B2m-KO(NMG)
Nomenclature
NOD.Cg-PrkdcscidIl2rgem1H2-Ab1em1H2-Aaem1H2-Eb1em1H2-Eb2em1H2-Ea-ps em1B2m em1Smoc
Cat. NO.
NM-NSG-014
Strain State
Repository Live
Model Description
Validation Data

Fig1. Detection of MHCII and B2m expression in spleen in MHCII/B2M-dKO (NMG) mice by RT-PCR.

Fig2. Expression characterization of mouse MHC I and MHC II in MHCII/B2M-dKO (NMG) mice.

Fig3. Hematology of MHCII/B2M-dKO (NMG) mice.

Fig4. Blood biochemistry of MHCII/B2M-dKO (NMG) mice.
For huPBMC immune reconstitution data, refer to huPBMC-(MHCII/B2M-KO NMG) NM-HU-263012. Click below for details.
huPBMC-(MHCII/B2M-KO NMG)-SMOC
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more